Aspirin enteric coated tablets 80mg

Enteric-coated aspirin tablets. Aspirin has an inhibitory effect on platelet aggregation. Therefore, the indications for enteric-coated aspirin tablets are as follows: to reduce the risk of acute myocardial infarction in suspected patients. Prevent the recurrence of myocardial infarction. Secondary prevention of stroke Reduce the risk of transient ischemic attack (TIA) and its secondary stroke. Reduce the risk of onset in patients with stable and unstable angina pectoris.